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Fine-needle aspiration cytology of 
head and neck masses: Is ultrasound 
guidance routinely warranted?
To the Editor: Fine-needle aspiration cytology (FNAC) is a simple, 
cheap and quick diagnostic procedure to differentiate infective 
from benign from malignant head and neck masses, and to direct 
management.[1] It also reduces surgical interventions and surgery-
related morbidity and anxiety.[2]
Palpation-guided FNAC has a high sensitivity, specificity and 
accuracy in excess of 90%, and non-diagnostic rates are <20%.[3] 
However, routine use of ultrasound guidance has been advocated in 
FNAC of palpable masses, especially with palpable thyroid nodules.[4]
Oncology and otolaryngology trainees at some South African 
(SA) training hospitals no longer perform freehand, palpation-
guided FNAC of masses in the head and neck, but refer patients 
for ultrasound-guided FNAC (USGFNAC). One of us (JJF) has 
also noted this to be the case in the private sector. USGFNAC adds 
expense, time and hospital visits for patients and hospitals and places 
an additional burden on radiology and pathology resources.
We question whether freehand, palpation-guided FNAC of neck 
masses should be advocated, especially in resource-constrained 
settings such as SA, and whether it should be included as an entrustable 
professional activity (EPA) in workplace-based assessments of trainee 
surgeons and oncologists.
A retrospective observational study was done to determine the 
non-diagnostic rate of freehand, palpation-guided FNAC with 
palpable head and neck masses in an SA setting. All patients who 
underwent FNAC for palpable head and neck masses in JJF’s surgical 
practice from 1 January 2014 to 31 December 2018 were included. 
A non-aspiration technique with a 23-gauge needle was used; 
only when there was a negative yield of material was an aspiration 
technique employed. Local anaesthesia was not used. The aspirate 
was ejected onto a glass microscope slide, a second microscope slide 
was used to smear the cellular material into a monolayer of cells, and 
a spray fixative was applied.
Of 281 aspirates, most were sampled from cervical lymph nodes 
(36%) and other cervical masses (27%) (Table 1). Thirty-seven 
aspirates were non-diagnostic (13%). One hundred and forty-
two aspirates (51%) were benign and 102 (36%) were malignant. 
Pleomorphic adenoma or reactive nodes were the most common 
benign diagnoses, and primary or metastatic squamous cell carcinoma 
was the most common malignant diagnosis.
The 87% diagnostic yield of freehand palpation-guided FNAC 
achieved in this study is similar to that reported in a large meta-
analysis by Gharib and Goellner[5] (83%). Choong et al.[3] found no 
statistically significant difference in non-diagnostic rates between 
palpation and USGFNAC when done for thyroid nodules (5.0% v. 
4.5%; p=0.53).
While USGFNAC adds value for non-palpable masses, cystic masses 
with a small solid component and non-diagnostic palpation-guided 
FNAC, we believe that it should not be routinely used (unless available in 
the doctor’s surgery) considering the high yield of freehand, palpation-
guided FNAC, as well as the expense, which in the USA is four times 
that of palpation-guided FNAC,[3] and the training and equipment 
required, including maintenance and cost of the machines. [6] Added 
to this is the need to prioritise use of available ultrasound machines 
and expertise for obstetrics and trauma in developing countries.[7] 
USGFNAC also adds expense, time and hospital visits for both patients 
and hospitals, places an additional burden on radiology and pathology 
services, and causes diagnostic delays.
Factors other than ultrasound guidance may affect the non-
diagnostic rate, such as the experience of the doctor performing the 
FNAC and the experience of the cytopathologist interpreting the 
biopsy. [8] The rate of non-diagnostic FNAC is also influenced by the 
number of needle passes, with 10 - 15 deemed adequate.[9] Learning 
and practising correct palpation-guided FNAC techniques should 
therefore be integral to training of oncologists and surgeons, and 
should form part of workplace-based assessment.
The results of this study support the use of freehand, palpation-
guided FNAC of neck masses, especially in resource-constrained 
settings such as SA. It should be included as an EPA in workplace-
based assessments of trainee surgeons and oncologists.
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Table 1. Summary of palpation-guided fine-needle aspiration 
cytology results (N=281)
n (%)
Total
Non-diagnostic 37 (13)
Benign 142 (51)
Malignant 102 (36)
Subsites  
Neck mass 77 (27)
Neck node 101 (36)
Parotid 45 (16)
Submandibular 5 (2)
Thyroid 17 (6)
Other 36 (12)
Diagnosis  
Metastatic SCC 55 (20)
Primary SCC 8 (3)
Reactive node 15 (5)
Pleomorphic adenoma 27 (10)
Non-diagnostic 37 (13)
Other 139 (49)
SCC = squamous cell carcinoma.
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